Emory, SpectRx Partner for Trials of Cervical Cancer Detection Device

SpectRx is partnering with Emory University as part of a grant to Emory from the Georgia Research Alliance to support FDA pivotal clinical trials for a new non-invasive cervical cancer detection device. The $64,700 matching grant will be used for the clinical trial of the SpectRx-developed technology at Grady Memorial Hospital under the guidance of Lisa Flowers of Emory University.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050215005183&newsLang=en)